Horak, Fay B.
Laird, Amy
Carlson-Kuhta, Patricia
Abrahamson, Melanie
Mancini, Martina
Orwoll, Eric S.
Lapidus, Jodi A.
Shah, Vrutangkumar V.
Funding for this research was provided by:
NIH (R41HD071760, R01 HD100383)
NIA; NIAMS; NCATS; NIH Roadmap for Medical Research (U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, UL1 TR000128.)
Article History
Received: 22 July 2022
Accepted: 12 October 2022
First Online: 27 October 2022
Declarations
:
: None for AL, PC-K, MA, MM, ESO, and JAL. OHSU, Dr. Horak, and Dr. Shah have a significant financial interest in APDM Wearable Technologies, a Clario company, which may have a commercial interest in the results of this research and technology. This potential conflict has been reviewed and managed by OHSU.